WEGO Medical, a subsidiary of Weigao Group, is a leading medical device manufacturer。WEGO Medical, a subsidiary of Weigao Group
Leukocyte Reduction Filter
Blood Bank
WEGO Medical's filters ensure safe transfusions by removing white blood cells, trusted globally for transfusion safety.
Previous
Next
WGLQ-001-001
Leukocyte Reduction Filter
WEGO Medical offers leukocyte reduction filters for safe blood transfusion. These filters remove white blood cells, reducing transfusion risks and ensuring recipient safety.
Utilizing advanced physical mechanisms, they preserve other essential blood components. They are the preferred choice for global blood banks and medical facilities, ensuring the safety and success of transfusions.
Overview
WEGO Medical offers leukocyte reduction filters for safe blood transfusion. These filters remove white blood cells, reducing transfusion risks and ensuring recipient safety.
Utilizing advanced physical mechanisms, they preserve other essential blood components. They are the preferred choice for global blood banks and medical facilities, ensuring the safety and success of transfusions.
Specifications
Properties
| Properties | Medical Polymer Products |
Additive Capacity
| AdditiveCapacity | CPDA-1,CPD-SAGM |
Tube material
| Tube material | PET/GLASS |
Supply Ability
| Supply ability | 1000000 Piece/Pieces per Month |
Documents
certificate
News
Read More »
WEGO Medical is pleased to invite global partners and industry professionals to visit us at the China International Medical Equipment Fair 2026, one of the
Abstract The study published in “Zhejiang Journal of Traumatic Surgery” investigates the role of transpedicular grafting of injectable artificial bone in promoting healing of fractured vertebrae
WEGO Medical will participate in the 12th AfSBT International Congress, scheduled to be held from 23–26 March 2026 in Windhoek, Namibia. AfSBT is an important
